Treatment | Page 367 of 465

Health :: Pharmion enrolled first patient into Vidaza Patient Registry

Pharmion Corporation (Nasdaq: PHRM) announced today the enrollment of the first patient in AVIDA(TM), a registry for patients treated with Vidaza(R) (azacitidine for injectable suspension). Vidaza was approved in May 2004 for the treatment of all five French-American-British (FAB) subtypes of myelodysplastic syndromes (MDS): refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) if accompanied by neutropenia or thrombocytopenia or requiring transfusions; refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL). Myelodysplastic syndromes are a serious and life-threatening group of diseases in which the bone marrow does not function normally, resulting in the production of malformed or immature blood cells.

Exercise :: Regular exercise plays a role in reducing fatigue, increasing energy

Forget so-called ?energy drinks.? A new analysis by University of Georgia researchers finds overwhelming evidence that regular exercise plays a significant role in increasing energy levels and reducing fatigue.

Plantar Fasciitis :: New stretch relieves pain from plantar fasciitis

A new stretch is proving quite effective to help treat and potentially cure plantar fasciitis, a condition that affects nearly 2.5 million Americans each year. In a study recently published in Journal of Bone and Joint Surgery, researchers found that patients suffering from the painful heel spur syndrome had a 75 percent chance of having no pain and returning to full activity within three to six months of performing the stretch. In addition, patients have about a 75 percent chance of needing no further treatment.

Dementia :: New dementia screening tool detects early cognitive problems

A screening tool for dementia developed by Saint Louis University geriatricians appears to work better in identifying mild cognitive problems in the elderly than the commonly used Mini Mental Status Examination, according to a new study.

Hepatitis :: Patients who recover from hepatitis C have lower risk of reinfection

A new study found that individuals who had tested positive for hepatitis C (HCV) but later tested negative for the virus were significantly less likely to become infected again compared to those who had never been infected, even though they had the same exposure risks.

Cancer :: Childhood cancer survivors treated with radiation face increased risk of tumors later in life

University of Minnesota cancer researchers found that children who received radiation treatment for cancer face an increased risk for brain and spinal column tumors later in life. The study will be published in the Nov. 1, 2006, issue of the Journal of the National Cancer Institute.

Health :: Predicting PET Imaging’s Future: Diagnosing and Treating Diseases ASAP

Breakthroughs in Sensitivity and Resolution Benefit Patients, Fundamentally Change How Doctors Will Diagnose and Treat Cancer and Heart, Brain Diseases, Notes Article in November Journal of Nuclear Medicine – Imagine a new world of detecting and diagnosing diseases sooner?even before any symptoms are present. Consider the possibility of receiving individualized, targeted molecular, cellular or genetic medical treatment as soon as possible and of undergoing scanning that can quickly tell your doctor whether your treatment is working. Continued advances in positron emission tomography (PET) imaging are key to this future, according to Simon R. Cherry, professor of biomedical engineering at the University of California, Davis.

Insomnia :: Psychological, behavioral therapies a reliable treatment for insomnia

Psychological and behavioral therapies produce reliable changes in several sleep parameters of insomniacs, and are, therefore, considered an effective treatment for insomnia. This finding confirms a review paper published in 1999 by the American Academy of Sleep Medicine (AASM) regarding the efficacy of psychological and behavioral treatments for insomnia.

Breast Cancer :: Unique estrogen receptor linked to metastatic breast cancer

Providence, RI ?V Breast cancer awareness month may have passed, but researchers remain focused on the disease with a new study showing that a unique estrogen receptor found in breast cancer tumors is a predictor of tumor size and metastases. The study, led by researchers at Rhode Island Hospital and Brown Medical School, is published in the November 1 issue of Clinical Cancer Research.

Depression :: Regular follow-up important during antidepressant treatment

Because individuals can react differently to antidepressant medications, regular follow-up is important during the first few weeks of treatment, according to an editorial by Group Health psychiatrist and researcher Greg Simon, MD, MPH.